While sales of immunity health products have been strong for most of 2020, consumer interest in other categories is also surging, from sleep and stress management to a resurgence in sports nutrition, says the COO of The Vitamin Shoppe.
Not all supplement and food ingredient manufacturers have benefited from pandemic demand upticks. RiceBran Technologies said consumers stocking their pantries with rice meant it had less raw material to work with, which hurt financial results.
The Federal Trade Commission charged Golden Sunrise Nutraceutical, Inc. with deceptively advertising an ‘Emergency D-Virus’ treatment as a scientifically proven way to treat COVID-19. The company even went as far as claiming their treatment was ‘FDA accepted.’
Over 70% of Americans take dietary supplements, and by now, most consumers have probably noticed the disclaimer that says "This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.”
The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).
Many recent warning letters from the Federal Trade Commission about COVID-19 are warranted, says UNPA’s Loren Israelsen, but some targeting health practitioners and what our industry has to offer in the broader immunity discussion may hint at redefining...